Heart disease continues to be the leading cause of death for men and women in the U.S., as well as a significant driver of health costs – over $200 billion each year from 2014 to 2015 – including the cost of health care services, medicine and lost productivity.
As American Heart Month gets underway this year, there is a renewed focus on encouraging measures that can be taken to prevent cardiovascular disease, such as regular physical activity and a healthy diet. It is also an important time to consider the therapies and devices that support people in the management of their heart health.
Together with the partners in our Research Network, NESTcc is undertaking multiple studies to leverage real-world data (RWD) generated in the routine course of clinical care – electronic health records (EHR), medical claims, patient-generated data, and others – to better understand the effectiveness of health technologies in cardiovascular care. Nearly one-third of NESTcc’s 21 real-world evidence (RWE) Test-Cases specifically explore device applications for the disease area, including studies in adult and pediatric populations.